33050-38-3, name is 3,6-Dichloro-[1,2,4]triazolo[4,3-b]pyridazine, belongs to chlorides-buliding-blocks compound, is considered to be a conventional heterocyclic compound, which is widely used in drug synthesis. The chemical synthesis route is as follows. Recommanded Product: 3,6-Dichloro-[1,2,4]triazolo[4,3-b]pyridazine
6. The 3,6-dichloro-1-methyl-1,2,4-triazolo [4,3-b]pyridazinium iodide was prepared from 3,6-dichloro-1,2,4-triazolo[4,3-b]pyridazine and methyl iodide in acetonitrile. N.m.r. in d6 DMSO: 4.38 (s, 3H); 8.45 (d, 1H); 9.12 (d, 1H).
The synthetic route of 33050-38-3 has been constantly updated, and we look forward to future research findings.
Reference:
Patent; Imperial Chemical Industries plc; ICI Pharma; US5049558; (1991); A;,
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics